During 2008-2022, cervical precancer incidence decreased by 79% and higher grade precancer incidence dropped by 80% among screened women between 20 and 24 years of age, the age group most likely to have been vaccinated with the HPV vaccine.
The HPV vaccine was first recommended in the United States in 2006 by the CDC’s Advisory Committee on Immunization Practices to prevent cancers and other diseases caused by HPV (MMWR Morb Mortal Wkly Rep 2025;74[6]:96-101).
“People should consult